BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leowattana W, Leowattana T. Chronic hepatitis B: New potential therapeutic drugs target. World J Virol 2022; 11(1): 57-72 [PMID: 35117971 DOI: 10.5501/wjv.v11.i1.57] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Agwamba EC, Louis H, Benjamin I, Apebende CG, Unimuke TO, Edet HO, Udoikono A, Nwagu AD, Adeyinka AS. (E)-2-((3-Nitrophenyl)Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking Investigations. Chemistry Africa 2022. [DOI: 10.1007/s42250-022-00468-4] [Reference Citation Analysis]
2 Turshudzhyan A, Tadros M. Cautious optimism in anticipation of hepatitis B curative therapies. World J Virol 2022; 11(4): 212-215 [DOI: 10.5501/wjv.v11.i4.212] [Reference Citation Analysis]